Unique ID issued by UMIN | UMIN000049524 |
---|---|
Receipt number | R000056383 |
Scientific Title | Verification study on the effects of intake of test foods on brain function. |
Date of disclosure of the study information | 2022/12/05 |
Last modified on | 2023/10/05 14:40:30 |
Verification study on the effects of intake of test foods on brain function.
Verification study on the effects of intake of test foods on brain function.
Verification study on the effects of intake of test foods on brain function.
Verification study on the effects of intake of test foods on brain function.
Japan |
Not applicable
Not applicable | Adult |
Others
NO
To examine the effects on brain function of 12 consecutive weeks of consumption of the test food in adult male and female subjects who are aware of memory and attention decline.
Efficacy
Cognitrax
Brain Age Meter ATMT (brain age [brain vitality, quickness, effective use of brain], stress intensity, brain traffic)
SF-36v2
POMS2
d-ROMs
BAP
Simple OSP (urinary 8-OHdG/creatinine corrected, PAO)
Oxidized LDL
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Daily intake of test food for 12 weeks
Daily intake of placebo (control food) for 12 weeks
20 | years-old | <= |
Not applicable |
Male and Female
1. Healthy Japanese men and women who are 20 years of age or older at the time of consent.
2. Persons who are aware of memory or attention decline.
3. Persons who are suspected to have mild cognitive impairment (MCI) with a score of 24 to 29 on the MMSE screening test for dementia.
4. Persons who have signed a consent form prior to the start of the study upon full explanation of the purpose and content of the study.
1. Persons with a pre-existing or current condition of liver disease, renal disease, cerebrovascular disease, diabetes, dyslipidemia, hypertension, or other chronic disease.
2. Persons who are on treatment for a serious illness.
3. Persons engaged in brain training, puzzles, etc. for the purpose of brain training.
4. Persons with food allergies or those who may be allergic to the test food.
5. Persons who regularly use licensed drugs or quasi-drugs that may affect the study.
6. Persons who regularly use health foods that may affect the study.
7. Persons who are participating in a clinical trial or have participated in another clinical trial within 3 months from the date of obtaining consent.
8. Smokers, or non-smokers who have not smoked within 3 months prior to the start of the study.
9. Persons unable to maintain daily routines.
10. Pregnant, lactating, or wishing to become pregnant.
11. Persons who plan to participate in other examinations during the study.
12. Other subjects who are deemed inappropriate for this study by the investigator.
100
1st name | Shuichi |
Middle name | |
Last name | Segawa |
Nissin York Co., Ltd.
Development Laboratories
348-0005
272, Tsutsumine, Kamimurakimi, Hanyu, Saitama, Japan
048-565-4686
shuichi.segawa@nissin.com
1st name | Ryoko |
Middle name | |
Last name | Koizumi |
APO PLUS STATION CO., LTD.
CRO Department Clinical Operations Division
103-0027
2-14-1,Nihonbashi,Chuo-ku,Tokyo, Japan
03-6386-8809
food-contact@apoplus.co.jp
APO PLUS STATION CO., LTD.
Nissin York Co., Ltd.
Profit organization
Watanabe Hospital
1-5-16, Haneda, Ota ward, Tokyo, Japan
03-3741-0223
wnb.cto@gmail.com
NO
医療法人社団 渡辺病院
2022 | Year | 12 | Month | 05 | Day |
Unpublished
Completed
2022 | Year | 11 | Month | 01 | Day |
2022 | Year | 11 | Month | 08 | Day |
2022 | Year | 12 | Month | 06 | Day |
2023 | Year | 04 | Month | 23 | Day |
2022 | Year | 11 | Month | 16 | Day |
2023 | Year | 10 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056383